K12 Training for Clinical and Translational Oncology Researchers

临床和转化肿瘤学研究人员的 K12 培训

• 批准号: 10647170
• 负责人: Erik Sulman
• 金额: $ 5.35万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-20 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10647170
• 关键词: Address; Cancer Patient; Clinical; Clinical Oncology; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Computational Biology; Creativeness; Dedications; Development; Educational Status; Ensure; Exposure to; Faculty; Fostering; Grant; Individual; Informatics; Infrastructure; Institution; Instruction; Investments; Malignant Neoplasms; Manuscripts; Medical Oncologist; Mentored Clinical Scientist Development Program; Mentors; Performance; Preparation; Productivity; Publications; Radiation Oncologist; Research; Research Personnel; Research Project Grants; Resources; Science; Surgical Oncologist; Time; Training; Translational Research; Work; Writing; anticancer research; career; career development; clinical training; cohort; expectation; experience; innovation; multidisciplinary; next generation; preservation; programs; research and development; responsible research conduct; skill acquisition; skills; success; translational impact; translational oncology

Abstract: A critical requirement to sustain the rapid advances in clinical oncology research that have been made over the last 20 years is to train and mentor the next generation of cancer clinician-investigators. Individuals who can write and carry out clinical trials that will promote increasing benefit for cancer patients are a crucial resource that must be preserved. The objectives of the NYU K12 Program are to provide the protected time which will foster the creativity, drive, and intellectual skills necessary to produce investigators who will make the key clinical discoveries in cancer research over the next few decades. We seek to equip scholars with career development skills that will guide them through productive careers as clinician-investigators. This first-time proposal is based on a record of training and mentoring outstanding clinical researchers while serving as junior faculty at NYU, the provision of a strong institutional commitment to support development of clinician investigators, representation of experienced and motivated medical, radiation and surgical oncologists among the mentors, an emphasis on informatics and computational biology and critical infrastructure that is part of an institutional Clinical and Translational Science Institute (CTSI) to leverage the strengths of the greater institution. NYU K12 scholars will complete training on the responsible conduct of research, general and targeted formal didactics instruction addressing proficiency in clinical and translational research, Master’s-level training in multidisciplinary clinical research, specialized course work, training in team science, individualized and didactic training in grant preparation, exposure to alternative career opportunities, and mentored performance of an innovative high- impact translational research project. Expectations at completion include publication of 2-3 first and/or senior author manuscripts and submission of a K- or R-level grant or equivalent. Three scholars yearly will dedicate 75% effort to research and career development activities for up to three years each, supervised by mentors with extensive and outstanding mentoring experience. A strongly invested K12 Executive Committee and a broad and diverse program faculty will promote each scholar’s mentoring. Our first aim is to provide personalized mentoring and didactic training to advance the clinical and translational research careers of our cohort of K12 scholars. Our second aim is to allow the K12 scholars to identify, choose and pursue research opportunities relevant to advancing the field of clinical oncology. Our third aim is to enable K12 scholars to establish multidisciplinary clinical and translational research networks and collaborations to ensure the success of their efforts and promote their careers in clinical oncology research.

摘要： 维持临床肿瘤学研究的快速发展的一个关键要求是， 过去20年的目标是培训和指导下一代癌症临床研究人员。个人谁可以 撰写和开展临床试验，将促进癌症患者的利益增加是一个至关重要的资源 必须保存下来NYU K12计划的目标是提供受保护的时间， 培养必要的创造力，驱动力和智力技能，以培养研究者，使其成为关键的临床研究者。 在未来几十年癌症研究中的发现。我们致力于为学者提供职业发展 技能，将引导他们通过生产性的职业生涯作为临床研究人员。这一首次提案是基于 在纽约大学担任初级教师期间， 提供强有力的机构承诺，支持临床研究人员的发展，代表 导师中有经验和积极的医学，放射和外科肿瘤学家，强调 信息学和计算生物学以及作为机构临床和 转化科学研究所（CTSI），以利用更大的机构的优势。NYU K12学者将 完成关于负责任地开展研究、一般和有针对性的正式教学法的培训 解决熟练的临床和转化研究，硕士水平的培训，多学科临床 研究，专业课程工作，团队科学培训，个性化和教学培训补助金 准备，接触其他职业机会，并指导创新的高绩效， 影响转化研究项目。完成时的预期包括出版2-3本第一和/或高级 作者手稿和提交K或R级补助金或同等学历。每年有三位学者 75%的努力，研究和职业发展活动，每三年，由导师监督， 广泛和出色的指导经验。一个强大的投资K12执行委员会和广泛的 和多样化的项目教师将促进每个学者的指导。我们的首要目标是提供个性化的 指导和教学培训，以推进我们的K12队列的临床和转化研究事业 学者我们的第二个目标是让K12学者识别，选择和追求研究机会 与推进临床肿瘤学领域有关。我们的第三个目标是使K12学者能够建立 多学科临床和转化研究网络和合作，以确保他们的成功 努力并促进他们在临床肿瘤学研究中的职业生涯。